Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III TH-004 (topical lidocaine gel) for postherpetic neuralgia
jRCT2031240211Phase 3Completed
- Sponsor
- Toyo Pharmaceutical
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postherpetic neuralgia (PHN) comparing TH-004 lidocaine gel with Placebo gel (2 arms). Primary endpoint: Analgesic response during the double-blind phase. Started Jul 2024; status: completed.
02
Drugs
lidocaine
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on jRCT2031240211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031240211.